Public consultation on harmonised classification and labelling
ECHA is looking for comments on the harmonised classification and labelling proposals for:
- Emamectin benzoate (ISO); (4’’R)-4’’-deoxy-4’’-(methylamino)avermectin B1 benzoate (EC -; CAS 155569-91-8). It has no harmonised classification and labelling in Annex VI to CLP. Comments are invited on selected physical hazards as well as hazards on human health and the environment except respiratory sensitisation, aspiration and hazardous to the ozone layer.
- Trinexapac-ethyl (ISO); ethyl 4-[cyclopropyl(hydroxy)methylene]-3,5-dioxocyclohexanecarboxylate; ethyl (1RS, 4EZ)-4-[cyclopropyl(hydroxy)methylene]-3,5-dioxocyclohexanecarboxylate (EC -; CAS 95266-40-3). It has no harmonised classification and labelling in Annex VI to CLP. Comments are invited on selected physical hazards as well as all human health hazards and hazards to the aquatic environment except respiratory sensitisation, aspiration and hazardous to the ozone layer.
- [S-(Z,E)]-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoic acid; S-abscisic acid (EC 244-319-5; CAS 21293-29-8). It has no existing harmonised classification and labelling in Annex VI to CLP. Comments are invited on selected physical hazards as well as on human health hazards and hazards to the aquatic environment except carcinogenicity, respiratory sensitisation, aspiration and hazardous to the ozone layer.
The deadline for comments is 11 January 2019, 23:59 Helsinki time.
Give comments
Court judgment on the classification of anthraquinone
On 24 October the General Court issued a judgment supporting the European Commission and ECHA in the case brought by DEZA, a.s., challenging the Commission’s decision on the classification of anthraquinone (EC 201-549-0; CAS 84-65-1) as a carcinogen, category 1B. In its judgment the General Court dismissed in its entirety the action brought by DEZA, a.s.
Having regard to the objectives to ensure a high level of protection of human health and the environment, the Court considered that Commission and ECHA’s Committee for Risk Assessment had not erred in their assessment that the substance met the criteria for classification as carcinogen, category 1B .
Judgment (currently only available in French and Czech)
|